Placeholder

Continued Outsourcing Expected

$30.00

Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at mwalsh@pharmavoice.com.

SKU: 2131. Categories: , .

Product Description

While global spending on new drug development has been growing at an annual rate of 9.1% during this past decade, spending on contract clinical services has been growing almost 50% faster, at an annual rate of 13.4%, according to the Tufts Center for the Study of Drug Development.
Even as the number of companies with active clinical projects worldwide increased by 80% between 2000 and 2008, sponsors have kept their R&D headcount level by working with CROs. The trend to work even closer — to improve R&D efficiency — will continue as both parties develop alliances in place of traditional transactional relationships.
Companies are moving toward the outsourcing of the entire development phase rather than components through new strategic…

Sidebars:
Factors that Contribute to a ­Successful R&D Transformation
Global Drug Discovery Outsourcing Market 2005-2013
The Conversion of Data into Insights

Experts
John Blakeley. Executive VP, ERT is a global provider of technology and services to the pharmaceutical, biotechnology, and medical-device industries. For more information, visit ert.com.
Susan Bornstein. Executive VP, eClinical Solutions, a division of Eliassen Group, which takes a strategic approach to managing clinical trial data by combining data management with statistical programming, reporting, and customized training solutions integrated with a clinical data repository to deliver a complete end-to-end data
management solution. For more information, visit eclinicalsol.com.
Paul Chung. Chief Operating Officer, Image Solutions Inc. (ISI) offers a range of software solutions and services to help pharma organizations navigate the licence applications publishing, and submission process, ensuring complete compliance with national and international format requirements as well as a suite of regulatory information management applications that drive, track, and manage postapproval commitments. For more information, visit imagesolutions.com.
Terri Cooper. Principal and National Leader, Life Sciences R&D Practice, Deloitte Consulting LLP, offers a menu of
professional services delivered in an integrated, collaborative approach that cuts across all segments of the health plan, health provider, and life-sciences industries. For more information, visit deloitte.com.
James J. DeSanti. CEO, PharmaVigilant, a SaaS company, provides broad technologies to streamline the clinical trial process for biopharmaceutical companies. For more information, visit pharmavigilant.com.
Glenn Gormley, M.D., Ph.D. Chief Science Officer, Co-head, Research & Development, Daiichi Sankyo, and Global Head of Development, President, Daiichi Sankyo Pharma Development (DSPD), is dedicated to the creation and supply of innovative pharmaceutical products to address the diversified, unmet medical needs of patients in both mature and emerging markets. For more information, visit dsi.com.
Jason Hwang, M.D. Executive Director of Health Care, Innosight Institute, a nonprofit, nonpartisan think tank whose mission is to apply Harvard Business School Professor Clayton M. Christensen’s theories of disruptive innovation to develop and promote solutions to the most vexing problems in the social sector. For more information, visit
innosightinstitute.org.
Beth Price. Executive VP, The Medical Affairs Company (TMAC), a provider of strategically aligned and customized MSL programs. For more information, visit themedicalaffairscompany.com.
Todd Reul. Director, Clinical Services, ClearTrial, which provides clinical trial operations (CTO) software that makes the planning, forecasting, and tracking of clinical project and financial performance faster and more accurate. For more information, visit cleartrial.com.
Graham Reynolds. VP, Marketing and Innovation Pharmaceutical Delivery Systems, West Pharmaceutical Services Inc., a global manufacturer of components and systems for injectable drug delivery, including stoppers and seals for vials, and closures and disposable components used in syringe, IV, and blood collection systems. For more information, visit westpharma.com.
Amar Sethi, M.D., Ph.D. VP, Science and Technology, Pacific Biomarkers (PBI) provides biomarker laboratory services and contract research services to support pharmaceutical and diagnostic manufacturers conducting human clinical trial research. For more information, visit pacbio.com.

FEEDBACK